 Aptorum APM stock is on the rise Wednesday after announcing approval to move forward with a clinical trial of its staph infection drug. The post APM Stock: 9 Things to Know About Aptorum as Shares Fly on Staph Infection Drug News appeared first on InvestorPlace. 